The United States Food and Drug Administration (USFDA) has conducted an inspection at our Bioequivalence Facility located at Vadodara from 3rd March, 2025 to 7th March, 2025. This was a scheduled inspection. The USFDA issued a Form 483 with one procedural observation.
The Company will provide comprehensive response to USFDA for the observations within the stipulated period.
The Company is committed to maintain the highest quality standards and compliance at all times.
Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 845.65 as compared to the previous close of Rs. 811.10. The total number of shares traded during the day was 4994 in over 523 trades.
The stock hit an intraday high of Rs. 861.00 and intraday low of 807.90. The net turnover during the day was Rs. 4230116.00. |
